NUV-1176

N/A

Report date: 2026/01/08 17:58:15

NME

Base Information

Drug NameNUV-1176

Drug Alias NameNUV-1176DDC-2

ClassificationSmall molecules

Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsEstrogen receptors modulators

TargetsPoly (ADP-Ribose) polymeraseEstrogen receptors

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNuvation Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A